Geron
IPO
- Headquarters
- Foster City, California
- Employees
- 201–500
- Founded
- 1990
- Business Model
- B2G
- Website
- geron.com
About
Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.